Shreenal Patel

Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study.

Alberto S. Pappo, Shreenal Patel, J. Crowley et al. · Journal of Clinical Oncology · 2010 · 43 citations

Medicine, Oncology, Pharmacotherapy +15

A SARC global collaborative phase II trial of R1507, a recombinant human monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R) in patients with recurrent or refractory sarcomas

Shreenal Patel, Alberto S. Pappo, J. Crowley et al. · Journal of Clinical Oncology · 2009 · 37 citations

Medicine, Oncology, Cancer Pharmacology +16

Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation

Winnie Ip, Juliana Silva, H. Bobby Gaspar et al. · Cytotherapy · 2018 · 24 citations · Full text

Medicine, Immunology, Pediatrics +13

Manufacture of GMP-compliant functional adenovirus-specific T-cell therapy for treatment of post-transplant infectious complications

Claire Horlock, Amanda Skulte, Arindam Mitra et al. · Cytotherapy · 2016 · 14 citations

Life Sciences, Biotechnology, Immunology +14